INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
SEC FORM 4/Open-market saleVerified data

Ball Bryan sold WHWK

See remarks · Whitehawk Therapeutics, Inc. · Common Stock

Side
SELL
Value
$179K
Shares
50.0K
Price
$3.57
Executed
Apr 9, 2026
Disclosed
Apr 13, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Apr 9 executedApr 13, 2026 disclosed

WHWK · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
33/ 100 · ELEVATED
Methodology →
  • Transaction type+12 / 20

    Open-market sale

  • Relative size+8 / 25

    $179K reported value · 8.7% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+5 / 15

    1 other actor traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · WHWK

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    5
    BB
    Ball BryanSee remarks
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A—
    91.6K sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    9
    GM
    Giacobello Scott M.CHIEF FINANCIAL OFFICER
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A—
    118.5K sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    9
    DM
    Dugan MargaretChief Medical Officer
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A—
    81.3K sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    2
    LJ
    Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A—
    194.0K sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    2
    LJ
    Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A—
    194.0K sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    9
    DD
    Dornan DavidChief Scientific Officer
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A—
    85.9K sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    9
    DD
    Dornan DavidChief Scientific Officer
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A—
    85.9K sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    5
    BB
    Ball BryanSee remarks
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A—
    91.6K sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    9
    DM
    Dugan MargaretChief Medical Officer
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A—
    81.3K sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    9
    GM
    Giacobello Scott M.CHIEF FINANCIAL OFFICER
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A—
    118.5K sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    9
    IK
    Iyengar Vijay KDirector
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A—
    76.1K sh
    		Sep 9, 2026Sep 11, 2026
    traded Sep 9, 2026
    		+2dSEC FORM 4

    Evidence

    9
    ZB
    Zhao BaitengDirector
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A—
    38.0K sh
    		Jun 12, 2026Jun 15, 2026
    traded Jun 12, 2026
    		+3dSEC FORM 4

    Evidence

    9
    DN
    Desai NeilDirector
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A—
    38.0K sh
    		Jun 12, 2026Jun 15, 2026
    traded Jun 12, 2026
    		+3dSEC FORM 4

    Evidence

    9
    LJ
    Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
    WHWKWhitehawk Therapeutics, Inc.
    Grant or award
    		A$200K
    51.0K sh
    		May 14, 2026May 18, 2026
    traded May 14, 2026
    		+4dSEC FORM 4

    Evidence

    29
    BB
    Ball BryanSee remarks
    WHWKWhitehawk Therapeutics, Inc.
    Open-market sale
    		SELL$91K
    26.4K sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    32
    BB
    Ball BryanSee remarks
    WHWKWhitehawk Therapeutics, Inc.
    Open-market sale
    		SELL$337K
    92.5K sh
    		Apr 14, 2026Apr 15, 2026
    traded Apr 14, 2026
    		+1dSEC FORM 4

    Evidence

    22
    BB
    Ball BryanSee remarks
    WHWKWhitehawk Therapeutics, Inc.
    Open-market sale
    		SELL$23K
    6,596 sh
    		Apr 10, 2026Apr 13, 2026
    traded Apr 10, 2026
    		+3dSEC FORM 4

    Evidence

    22
    LJ
    Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
    WHWKWhitehawk Therapeutics, Inc.
    Open-market sale
    		SELL$49K
    14.5K sh
    		Apr 9, 2026Apr 10, 2026
    traded Apr 9, 2026
    		+1dSEC FORM 4

    Evidence

    32
    LJ
    Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
    WHWKWhitehawk Therapeutics, Inc.
    Open-market sale
    		SELL$323K
    94.1K sh
    		Apr 7, 2026Apr 8, 2026
    traded Apr 7, 2026
    		+1dSEC FORM 4

    Evidence

    29
    LJ
    Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
    WHWKWhitehawk Therapeutics, Inc.
    Open-market sale
    		SELL$217K
    63.9K sh
    		Apr 8, 2026Apr 8, 2026
    traded Apr 8, 2026
    		+0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001766522-26-000009
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Apr 9, 2026
    Published
    Apr 13, 2026
    Ingested by INSIDER
    Nov 5, 04:05 UTC
    Last re-read
    Nov 5, 04:05 UTC

    Extracted facts

    Filer
    Ball Bryan
    Role
    See remarks
    Transaction
    Open-market saleAs filed: “S”
    Asset
    Whitehawk Therapeutics, Inc.
    Ticker
    WHWK
    Shares
    50.0K
    Price per share
    $3.57
    Value
    $178,500
    Execution date (reported)
    Apr 9, 2026
    Owned after transaction
    522.6K shares
    Days from execution to publication
    4

    Calculation

    Value = shares × reported price per share

    • Shares: 50.0K
    • Price: $3.57

    = $178,500

    What this establishes

    Ball Bryan filed this Form 4 reporting a open-market sale of WHWK on Apr 9, 2026. It became public on Apr 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    See remarks
    Ball Bryancik:0001766522
    Issuer
    Whitehawk Therapeutics, Inc.cik:0001422142

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.